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Abstract
Background: The use of Akkermansia muciniphila as potential therapeutic intervention is receiving increasing
attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting
anti-inflammatory effects. The abundance of A. muciniphila is associated with a healthy gut in early mid- and later
life. However, the effects of A. muciniphila on a decline in intestinal health during the aging process are not
investigated yet. We supplemented accelerated aging Ercc1−/Δ7 mice with A. muciniphila for 10 weeks and
investigated histological, transcriptional and immunological aspects of intestinal health.
Results: The thickness of the colonic mucus layer increased about 3-fold after long-term A. muciniphila
supplementation and was even significantly thicker compared to mice supplemented with Lactobacillus plantarum
WCFS1. Colonic gene expression profiles pointed towards a decreased expression of genes and pathways related to
inflammation and immune function, and suggested a decreased presence of B cells in colon. Total B cell
frequencies in spleen and mesenteric lymph nodes were not altered after A. muciniphila supplementation. Mature
and immature B cell frequencies in bone marrow were increased, whereas B cell precursors were unaffected. These
findings implicate that B cell migration rather than production was affected by A. muciniphila supplementation.
Gene expression profiles in ileum pointed toward a decrease in metabolic- and immune-related processes and
antimicrobial peptide production after A. muciniphila supplementation. Besides, A. muciniphila decreased the
frequency of activated CD80+CD273− B cells in Peyer’s patches. Additionally, the increased numbers of peritoneal
resident macrophages and a decrease in Ly6Cint monocyte frequencies in spleen and mesenteric lymph nodes add
evidence for the potentially anti-inflammatory properties of A. muciniphila.
Conclusions: Altogether, we show that supplementation with A. muciniphila prevented the age-related decline in
thickness of the colonic mucus layer and attenuated inflammation and immune-related processes at old age. This
study implies that A. muciniphila supplementation can contribute to a promotion of healthy aging.
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Background
Coincident with the increase in the aged population that
is observed nowadays, the often inevitable decline in
overall health in the elderly is becoming an alarming
problem. The aging process is accompanied by a chronic
low-grade inflammatory state, termed ‘inflamm-aging’,
which is a strong risk factor for many age-related path-
ologies [1–4]. One of the organs that is affected by the
aging process is the intestinal tract and the occur-
rence of gut-related disorders in the aged population
is considerable [5].
As main inhabitant of the intestine, the gut microbiota
play an essential role in the maintenance of overall health.
Bacteria are able to degrade complex carbohydrates,
thereby converting these substrates into metabolites that
are beneficial to health, such as short-chain fatty acids
(SCFAs) [6, 7]. Besides, the gut microbiota interact exten-
sively with the host immune system by the regulation of
immune responses [8]. During the aging process, changes
in gut microbiota composition occur, such as a decreased
diversity, a decrease in health-promoting bacteria and an
increase in potential pathobionts. This disturbed balance
in microbiota composition is thought to increase the
risk of impaired intestinal barrier function and intes-
tinal inflammation [9]. In mice, transfer of microbiota
from aged mice to young germfree recipient mice pro-
moted intestinal inflammation, increased leakage of
bacterial components into blood and stimulated sys-
temic immune activation [10].
An important factor with regard to gut health is the
mucus layer that covers the intestinal epithelial cell
layer and serves as physical protection for bacterial
penetration and harmful compounds to enter the mu-
cosal tissue [11]. Intestinal mucus is built up of mostly
Mucin 2 (Muc2) proteins, which are large gel-forming
proteins that are secreted by goblet cells located in the
intestinal mucosa. These proteins form a net-like struc-
ture and are the building blocks of the mucus layer.
The importance of the mucus layer was emphasized in
studies using Muc2 knockout mice, which did not have
a colonic mucus layer covering the intestinal epithelial
layer [12, 13]. These mice suffered from a decreased in-
testinal barrier function, an increased inflammatory
status [14] and had signs of colitis [12]. Next to the
protective function of the mucus layer, it also serves as
an energy source for bacteria. Akkermansia muciniphila
is one of the bacterial species that is able to degrade
mucus. This bacterium is highly abundant (~ 3%) in the
healthy human colon [15]. Upon mucus degradation, A.
muciniphila produces several immune-stimulating com-
pounds, such as SCFAs and pili [16, 17]. The outer
membrane pili-like protein Amuc_1100 is thought to
be involved in the beneficial properties of A. mucini-
phila on health [18, 19].
Recent studies suggest that the beneficial effects of A.
muciniphila are not limited to the intestinal tract, but
extend to overall health. The abundance of A. mucini-
phila was reduced in people suffering from obesity, type
2 diabetes, inflammatory bowel disease, amongst others
[20]. Furthermore, supplementation with A. muciniphila
in mice resulted in an improved metabolic state and
reduced diet-induced obesity (ClinicalTrials.gov Identi-
fier: NCT02637115) [21–23].
We and others previously showed that the abundance of
Akkermansia spp. in colonic luminal content decreased
during aging in mice [10, 24, 25]. Another study also re-
ported an age-related loss of Akkermansia spp. in humans
[26]. Interestingly, the abundance of Akkermansia spp. was
shown to be increased in centenarians (105–109 years old)
compared to younger age groups [27]. These results could
indicate that a relation exists between reaching an extreme
old age and the abundance of Akkermansia spp. [24, 27].
The numerous potential beneficial characteristics of A.
muciniphila suggest that this bacterium could be a po-
tent candidate for microbial supplementation. However,
the effects of this bacterium on the decline in intestinal
health as seen during aging are not widely investigated yet.
Therefore, the aim of the present study was to investigate
the effects of supplementation with A. muciniphila on dif-
ferent aspects of intestinal health. We used Ercc1−/Δ7 mice,
an accelerated aging mouse model that has a median life-
span of ~ 20 weeks. Further characteristics of this mouse
model were extensively described in previous studies
[28–30] and indicate that the accelerated aging pheno-
type of Ercc1−/Δ7 mice largely resembles normal aging.
The Ercc1−/Δ7 mice were supplemented with A. mucini-
phila for 10 weeks via oral gavage. After sacrifice, ileum
and colon were subject to transcriptional analysis and the
microbiota composition in these organs was investigated.
Furthermore, we assessed mucus thickness in the colon
and the distribution of immune cells in immune-related
tissues.
Results
A. muciniphila supplementation increased mucus
thickness in the colon of Ercc1−/Δ7 mice
Since A. muciniphila is a mucus-colonizing bacterium and
utilizes mucus as energy source, we investigated whether
supplementation with A. muciniphila had an effect on the
mucus layer in the colon of Ercc1−/Δ7 mice. Measurements
of mucus thickness in PAS/Alcian Blue stained colon tissue
revealed that the mucus layer was significantly thicker in
the mice supplemented with A. muciniphila compared to
the control group (p < 0.001) (Fig. 1a-c). Besides, the results
were compared with the mucus thickness of mice supple-
mented with L. plantarum (WCFS1), since we showed pre-
viously that supplementation with this bacterium prevented
an age-related decline in mucus thickness [29]. The colonic
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mucus layer of L. plantarum supplemented mice was
thicker compared to the control group (p < 0.001)
(Fig. 1a, d), but supplementation with A. muciniphila
resulted in a significantly thicker mucus layer than the L.
plantarum supplemented mice (p < 0.001) (Fig. 1a). These
results show that supplementation with A. muciniphila
contributed to the prevention of a decreased mucus layer
thickness at old age.
No differences in colonic and ileal microbiota
composition after supplementation with A. muciniphila
In order to investigate whether supplementation with A.
muciniphila caused changes in gut microbiota compos-
ition, we performed 16S rRNA gene sequencing on co-
lonic and ileal content. Alpha-diversity (Shannon entropy)
of colonic and ileal content samples did not differ between
the control and supplemented mice (Fig. 2a). To investi-
gate whether supplementation with A. muciniphila re-
sulted in an increased colonization of this bacterium, the
relative abundance of Akkermansia spp. in colonic content
was assessed. In colonic content, the average relative
abundance was slightly higher in the intervention
group (0.738 ± 1.279%) compared to the control group
(0.252 ± 0.503%) (Fig. 2b), but this difference was not
statistically significant. Akkermansia spp. was not present
in ileal content, except for one mouse in the intervention
group (data not shown). Variation in microbial compos-
ition between samples was represented in a principal coor-
dinates analysis (PCoA) based on Bray-Curtis dissimilarity.
In both colon and ileum samples, no clear separation was
observed between the control and A. muciniphila group
(Fig. 2c-d). Furthermore, no statistically significant differ-
ences at genus level between the control and supplemented
mice was found in both sources (data not shown). These
data show that bacterial supplementation with A. mucini-
phila three times a week did not result in changes in gut
microbiota composition of Ercc1−/Δ7 mice.
A. muciniphila supplementation minimally altered the
expression of genes involved in intestinal barrier function
in colon
To explore the effects of supplementation with A. mucini-
phila on gene expression, transcriptome analysis was per-
formed on mRNA isolated from colon and ileum tissue of
Ercc1−/Δ7 mice. In colon, a number of 427 genes was signifi-
cantly differentially expressed (p < 0.05, fold change > 1.2
or < − 1.2) between the control and A. muciniphila group,
comprising 225 up-regulated and 202 down-regulated
genes. Since a highly significant increase in mucus thick-
ness was observed in the colon of mice that received A.
muciniphila, colonic expression of genes related to mucus
production was investigated. No significant differential
expression of mucins was observed, except Mucin like
1 (Mucl1) which was down-regulated (− 1.5-fold) in the
A. muciniphila group compared to the control mice
(Additional file 1). Besides, to explore if an increased
mucus thickness in the colon resulted in an enhanced
intestinal barrier function, expression of genes related
to tight junction function was investigated. The classical
tight junction proteins Tjp 1–3, Jam 1–3, Claudin family
and Ocln were not differentially expressed (data not
shown). To investigate which pathways were regulated in
colon by A. muciniphila supplementation, Gene Set En-
richment Analysis (GSEA) was performed. Significantly
enriched pathways were dominated by cell cycle related
processes, but no pathways related to intestinal barrier
function were observed (Additional file 2).
Fig. 1 Mucus thickness increased in Ercc1−/Δ7 mice supplemented with Akkermansia muciniphila. a Mucus thickness (μm) measured in colon of
Ercc1−/Δ7 mice in the control, A. muciniphila group and L. plantarum group. b Representative picture of PAS/Alcian Blue staining in control
mouse, (c) mouse supplemented with A. muciniphila and (d) L. plantarum. Data represent the mean + SEM from three to five mice per group.
***p < 0.001. Scale bars histological images: 100 μm
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Supplementation with A. muciniphila decreased
expression of genes and pathways related to
antimicrobial activities, metabolic processes and mucus
biosynthesis in ileum
Since supplementation with A. muciniphila minimally al-
tered the expression of genes related to intestinal barrier
function in colon, we also investigated gene expression
profiles in ileum tissue of Ercc1−/Δ7 mice. A number of 795
genes was significantly differentially expressed (p < 0.05,
fold change > 1.2 or < − 1.2) between the control and A.
muciniphila group in ileum, comprising 425 up-regulated
and 370 down-regulated genes. Interestingly, several genes
encoding for antimicrobial peptides were down-regulated
in the A. muciniphila supplemented mice, i.e. Reg3b
and Reg3g (Fig. 3a, b; Additional file 3). However, the
expression of genes encoding for alpha-defensins and
lysozymes was not affected by A. muciniphila supple-
mentation. Tight junction genes were minimally differen-
tially expressed, only Cldn2 and Cldn8 were
down-regulated in ileum of mice supplemented with A.
muciniphila compared to the control group (Fig. 3c, d;
Additional file 3). GSEA revealed that significantly enriched
down-regulated pathways were dominated by metabolic
processes (Additional file 2). Besides, the pathways “N-Gly-
can Biosynthesis” and “Biosynthesis of the N-Glycan Pre-
cursor (Dolichol Lipid-Linked Oligosaccharide, LLO) and
Transfer to a Nascent Protein” were down-regulated in
ileum of mice that received A. muciniphila supplementa-
tion compared to the control group (Additional file 2).
Based on this finding, the microarray data set was
searched for genes related to mucus biosynthesis. The
genes Ctnna3 and St6galnac6 were down-regulated in
ileum in the supplemented mice versus control group
(Fig. 3e, f; Additional file 3).
Decreased expression of genes and pathways related
to inflammation and immune function in colon and ileum
after A. muciniphila supplementation
As immune function is an important factor regarding intes-
tinal health, expression profiles of genes related to immune
A B
C D
Fig. 2 Microbiota composition in colon and ileum of Ercc1−/Δ7 mice supplemented with Akkermansia muciniphila. a Alpha-diversity (Shannon
entropy) measured in ileum and colon samples. Boxes extend from the 25th to 75th percentile, middle line represents median, and whiskers
represent minimum and maximum values. b Relative abundance (%) of Akkermansia spp. in colonic content assessed by 16S rRNA sequencing.
Data represent mean + SEM (c) Beta-diversity measured by Bray-Curtis Principal Coordinate Analysis in colon samples and (d) ileum samples.
Between four and six mice per group were used for microbiota analysis
van der Lugt et al. Immunity & Ageing            (2019) 16:6 Page 4 of 17
response were investigated. Remarkably, down-regulated
genes in both colon and ileum were dominated by genes
encoding for immunoglobulins (Additional file 1). In
the colon, several genes encoding for chemokines, such
as Cxcl13 (Fig. 4a; Additional file 3) and Ccl12, as well
as the cytokine Il5 and the complement factors C1ra
and C5ar1 were all down-regulated (Additional file 1).
Also the immunoglobulin receptor Pilrb1 had a decreased
expression in the colon of the A. muciniphila group
(Additional file 1). Additionally, other immune-related
genes were down-regulated in the colon of A. mucini-
phila supplemented mice compared to the control
group, e.g. Blk, Cd4, Cd72, Tlr7 and Tlr12 (Fig. 4b-f;
Additional file 3). GSEA revealed that immune-related
pathways were down-regulated in colon, for example “Intes-
tinal Immune Network for IgA Production”, “Cytokine-Cy-
tokine Receptor Interaction” and “Inflammatory Response
Pathway”, amongst others (Additional file 2). Moreover, In-
genuity pathway analysis (IPA) identified seven cytokines as
upstream regulators that were predicted to be inhibited
after supplementation with A. muciniphila, including
both the pro-inflammatory Il1 and anti-inflammatory
Tgf-beta (Table 1). Also other inflammation-related factors,
such as Myeloid differentiation primary response 88
(Myd88), Tumor necrosis factor receptor superfamily mem-
ber 1B (Tnfrsf1b) and 12 (Tnfsf12), NFKB Inhibitor Alpha
(Nfkbia), T cell receptor (TCR) and Toll Like Receptor
Adaptor Molecule 1 (Ticam1) were predicted inhibited
upstream regulators (Table 1). In ileum, GSEA anno-
tated the pathway “Antigen Presentation: Folding, as-
sembly and peptide loading of class I MHC” as highly
up-regulated (Additional file 2). The most significant up-
stream regulator identified by IPA in ileum tissue was Inter-
leukin 10 Receptor Subunit Alpha (Il10RA), which was
A B C
D E F
Fig. 3 Microarray analysis performed on mRNA isolated from ileum tissue. a Log2 microarray intensities of Regenerating islet-derived 3 beta
(Reg3b), (b) Regenerating islet-derived 3 gamma (Reg3g) (c) Claudin 2 (Cldn2), (d) Claudin 8 (Cldn8), (e) Catenin (cadherin associated protein),
alpha 3 (Ctnna3) and (f) ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (St6galnac6).
Data represent mean + SEM. Control: n = 5, A. muciniphila: n = 6. *p < 0.05; **p < 0.01
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predicted to be slightly inhibited after A. muciniphila sup-
plementation (Table 2). Taken together, these results show
that A. muciniphila supplementation decreased the ex-
pression of numerous genes and pathways related to
inflammation and immune function in both colon and
ileum.
Minor changes in local B cell distribution after A.
muciniphila supplementation
Based on the findings of the microarray analysis, we
continued with the investigation of immune cell distri-
bution in different organs of the immune system. Since
several B cell related genes were down-regulated after A.
muciniphila supplementation, such as immunoglobulin
genes (both in ileum and colon), and Blk (only in colon),
we first focused on the local distribution of B cells. In
mesenteric lymph nodes (MLN) and Peyer’s patches
(PP), no differences in B cell frequencies between groups
were observed (Fig. 5a-c). However, in PP the frequency of
activated CD80+CD273− B cells was significantly lower in
the supplemented mice (p = 0.009) (Fig. 5d). Furthermore,
frequencies of more immature CD80−CD273− B cells
were significantly higher in the A. muciniphila group
(p = 0.03) (Fig. 5e), whereas no changes were observed
in CD80+CD273+ memory-like and CD80−CD273+ B cells
(Fig. 5f, g) [31].
A. muciniphila supplementation increased the migration
of B cells into spleen and BM
Next, we continued with investigation of B cell subsets in
spleen and bone marrow (BM). The frequency of total B
cells in spleen was not different between groups (Fig. 6a).
Also other B cell subsets in spleen, such as immature,
follicular and marginal zone B cells, were not significantly
A B C
D E F
Fig. 4 Microarray analysis performed on mRNA isolated from colon tissue. a Log2 microarray intensities of (a) C-X-C motif chemokine ligand 13
(Cxcl13), (b) B lymphoid kinase (Blk), (c) Cluster of differentiation 4 (Cd4), (d) Cluster of differentiation 72 (Cd72), (e) Toll-like receptor 7 (Tlr7), (f)
Toll-like receptor 12 (Tlr12). Data represent mean + SEM. Control group: n = 5. A. muciniphila group: n = 6. *p < 0.05; **p < 0.01; ***p < 0.001
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different between groups (data not shown). However, the
frequency of B1 cells in spleen was significantly higher in
the A. muciniphila supplemented mice (p = 0.02) (Fig. 6b,
c). In bone marrow (BM), a trend of higher frequencies of
total B cells was observed in A. muciniphila supplemented
mice compared to control mice (p = 0.07) and frequencies
of mature and immature B cells were also higher (p = 0.02
and 0.06, respectively) (Fig. 6d-g). Frequencies of B cell pre-
cursors, i.e. pro-B cells, small resting pre-B cells and large
cycling pre-B cells were not different between groups
(Fig. 6h-j). These data suggest that A. muciniphila sup-
plementation did not change production of new B cells
in BM, but increased migration of B cells into the spleen
and BM.
T cell distribution in MLN and spleen was unaltered after
A. muciniphila supplementation
Transcriptome analysis showed that expression of the Cd4
gene was decreased in the colon of mice that received A.
muciniphila compared to the control mice. Moreover, IPA
revealed T cell receptor (TCR) as predicted inhibited
upstream regulator in colon. Therefore, we investi-
gated whether the distribution of T cells was altered
between groups in spleen and MLN. However, CD4+
and CD8+ T cell distributions in MLN and spleen were
not different compared to the control group, neither
were CD4+FoxP3+ Treg frequencies changed in both
immune tissues (Fig. 7a-f ).
Decreased inflammatory cell populations in spleen and
MLN after A. muciniphila supplementation
Next, since GSEA revealed an enrichment of pathways re-
lated to inflammatory response and immune function, we
investigated whether inflammatory cell frequencies were al-
tered after supplementation of Ercc1−/Δ7 mice. In spleen,
the frequencies of total and Ly6Chi monocytes were slightly
lower in the A. muciniphila group and Ly6Cint monocytes
were significantly lower (p = 0.01) (Fig. 8a-d). Besides, the
frequency of neutrophils was also slightly lower in the sup-
plemented mice (Fig. 8e). The same trends of these inflam-
matory cell populations were found in MLN, although cell
Table 1 Upstream regulators in colon identified by Ingenuity
pathway analysis based on the comparison between Ercc1−/Δ7
mice receiving A. muciniphila supplementation and control mice
Upstream Regulator Activation z-score p-value of overlap
ACOX1 2.24 0.013
Alpha catenin 2.00 0.029
ID3 1.98 0.030
SOCS1 1.95 0.040
CDKN2A 1.72 0.025
MYD88 −2.41 0.045
IL1 −2.38 0.049
TNFRSF1B −2.22 0.003
CHUK −2.21 0.017
GATA6 −2.21 0.036
NFKBIA −2.17 0.029
Akt −2.16 0.020
cytokine −1.99 0.000
Nfat (family) −1.98 0.014
CCND1 −1.98 0.044
WNT5A −1.95 0.033
CTNNB1 −1.95 0.037
Tgf beta −1.94 0.010
EGR1 −1.91 0.035
Interferon alpha −1.78 0.004
LTBR −1.72 0.001
STAT3 −1.71 0.024
TCR −1.60 0.029
TNFSF12 −1.58 0.004
TNF −1.54 0.036
SSB −1.52 0.000
IL17A −1.40 0.002
TICAM1 −1.40 0.003
HRAS −1.39 0.031
E2F1 −1.36 0.009
IL6 −1.34 0.005
PRKACA −1.21 0.001
IL1B −1.21 0.003
Cut-off values include p < 0.05 and activation z-score < − 1.2 or > 1.2. Upstream
regulators in bold are involved in inflammation- and
immune-related processes
Table 2 Upstream regulators in ileum identified by Ingenuity
pathway analysis based on the comparison between Ercc1-/Δ7
mice receiving A. muciniphila supplementation and control mice
Upstream Regulator Activation z-score p-value of overlap
HMGA1 1.66 0.002
POR 1.46 0.000
SYVN1 1.34 0.006
CFTR 1.25 0.000
AR −2.74 0.005
NR1I2 −2.00 0.042
BRCA1 −1.98 0.016
CTNNB1 −1.72 0.001
LEP −1.60 0.031
MAPK14 −1.34 0.020
IL10RA −1.31 0.000
Cut-off values include p < 0.05 and activation z-score < − 1.2 or > 1.2. Upstream
regulators in bold are involved in inflammation- and
immune-related processes
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frequencies were low (< 1%, data not shown). These data
reveal a minor decrease in inflammatory markers in spleen
and MLN after A. muciniphila supplementation in
Ercc1−/Δ7mice. In addition, we assessed if we could iden-
tify any signs of immune cell infiltration by investigating
H&E stained tissue. For both colon and ileum tissue, no
histological signs of immune cell infiltration were ob-
served in the control and A. muciniphila group (Fig. 8f).
Increased numbers of CD11b+ cells and resident
macrophages in peritoneum of Ercc1−/Δ7 mice
supplemented with A. muciniphila
Since we found a higher abundance of B1 cells in spleen
and this cell type is generally highly enriched in the peri-
toneal cavity, we also investigated the distribution of im-
mune cells in the peritoneum. Remarkably, the total
number of peritoneal cells in mice supplemented with A.
muciniphila was nearly 3-fold higher than in the control
mice (p = 0.02) (Fig. 9a). The absolute numbers of B
cells, B1 cells and T cells did not significantly differ be-
tween groups (Fig. 9b-d). We found an increase in abso-
lute numbers of CD11b+ cells in the peritoneum after A.
muciniphila supplementation (p = 0.004) (Fig. 9e). Inves-
tigation of CD11b+ cell subsets revealed that absolute
numbers of neutrophils were not significantly higher
after A. muciniphila supplementation (Fig. 9f ), in con-
trast to resident macrophages (p = 0.045) (Fig. 9g, h). In
addition, the expression of CD115 on resident macro-
phages was significantly higher in the A. muciniphila
group compared to the control group (p = 0.02) (Fig. 9i),
whereas no change in the expression of CD11b and
SIRPα was observed (Fig. 9j, k).
A
D E F G
B C
Fig. 5 Distribution of B cell subsets in mesenteric lymph nodes (MLN) and Peyer’s patches (PP) after supplementation with Akkermansia
muciniphila. a Mean frequency of B cells in MLN. b Flow cytometric analysis of B cells in PP. c Mean frequency of B cells in PP. d Mean frequency
of CD80+CD273− B cells, (e) CD80−CD273− B cells, (f) CD80+CD273+ B cells and g CD80−CD273+ B cells in PP. Data represent the mean + SEM
from five to six mice per group. *p < 0.05; **p < 0.01
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A. muciniphila supplementation did not alter survival,
body weight and organ weights of Ercc1−/Δ7 mice
Supplementation with A. muciniphila for 10 weeks did
not alter survival rates as compared to the control mice
(Additional file 4). Body weight of Ercc1−/Δ7 mice in-
creased in the first half of life, but decreased again from
11 weeks of age onwards (Additional file 4). No pro-
nounced differences in body weight development were
found between groups. The weight of liver, spleen
and thymus measured directly after sacrifice were not
significantly different between control and A. mucini-
phila group (data not shown).
Discussion
The bacterium Akkermansia muciniphila is suggested to
be a promising microbial supplement, due to its benefi-
cial effects on health [20, 32]. However, its effects on the
decline in intestinal health during aging are not well
A
E F
B C D
G H I J
Fig. 6 Distribution of B cell subtypes in spleen and bone marrow (BM) after supplementation with Akkermansia muciniphila. a Mean frequencies
of CD19+CD3− B cells in spleen. b Flow cytometric analysis of live single CD19+CD3− cells in spleen. c Mean frequencies of CD5+CD43+ B1 cells in
spleen. d Mean frequencies of B cells in BM. e Flow cytometric analysis of live single CD19+ cells, divided in pro-B cells, large cycling pre-B cells
and small resting pre-B cells in BM. f Mean frequencies Mature B cells, g Immature B cells, h Pro-B cells, i Small resting pre-B cells and (j) Large
cycling pre-B cells in BM. Data represent the mean + SEM from four to six mice per group. *p < 0.05
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investigated yet. In the present study, we investigated
the effects of supplementation with A. muciniphila on
different aspects of intestinal health in accelerated
aging Ercc1−/Δ7 mice. We report that supplementation
with A. muciniphila for 10 weeks resulted in a signifi-
cantly thicker colonic mucus layer and an improve-
ment of anti-inflammatory immune status compared
to the control group.
In two recent studies, it has been shown that the co-
lonic mucus layer decreased in aging mice, suggesting
an association with bacterial penetration and immune
activation [29, 33]. An aging-related decrease in mucus
thickness was also observed in Ercc1−/Δ7 mice [29], con-
firming the similarity in aging phenotype in this acceler-
ated aging mouse model compared to a mouse model
with a normal aging process. We previously showed that L.
plantarum WCFS1 increased the thickness of the colonic
mucus layer in Ercc1−/Δ7 mice [29], but we now show that
A. muciniphila is capable to even further thicken the mucus
layer. The ability of A. muciniphila to increase mucus thick-
ness was also reported before [23]. A. muciniphila is able to
degrade mucin structures to use it as carbon and nitrogen
source and is therefore called a mucus-degrader [17].
Nevertheless, the observed increased mucus layer thickness
after supplementation suggests that this bacterium is
able to actively turn on host colonic mucus produc-
tion, a suggestion that has also been made by Derrien
and colleagues [34]. Interestingly, we did not find dif-
ferential expression of any genes encoding for mucins,
apart from a down-regulation of Mucl1 in colon tis-
sue. However, expression levels of this gene were low
and it is not a typical mucin that constitutes the co-
lonic mucus layer, such as Muc2 [35]. In our previous
study, supplementation with L. plantarum WCFS1 did
neither result in differences in mucin gene expression,
while a significantly increased colonic mucus thick-
ness was observed [29]. Possibly, supplementation
with A. muciniphila resulted in an increased mucus
thickness by impacting mucus biosynthesis processes
without affecting Muc2 expression. In order to under-
stand the exact underlying mechanisms of the mucus
turnover processes, further investigation is warranted.
Interestingly, in the ileum of A. muciniphila supple-
mented mice, GSEA revealed a down-regulation of two
pathways related to N-Glycan biosynthesis and besides,
two genes related to mucus biosynthesis were also
A B C
D E F
Fig. 7 Distribution of T cells in mesenteric lymph nodes (MLN) and spleen after supplementation with Akkermansia muciniphila. a Mean
frequencies of CD4+ T cells and (b) CD8+ T cells and (c) FoxP3+ Treg cells in MLN. d Mean frequencies of CD4+ T cells and (e) CD8+ T cells and (f)
FoxP3+ Treg cells in spleen. Data represent the mean + SEM from five to six mice per group
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down-regulated. These results imply that, besides its
great impact on the colonic mucus layer, A. mucini-
phila could also have had an effect on the ileal mucus
layer. We could not verify this finding by measuring
the ileal mucus layer, because of its rather discontinu-
ous appearance due to the presence of villi.
Next to the important function of the mucus layer,
tight junctions (TJs) sealing the intestinal epithelial
cells also play an important role in intestinal barrier
function and an age-related decreased expression of
TJ genes was found in baboons [36]. We and others
previously showed that A. muciniphila improved intes-
tinal barrier function in a Caco-2 cell model [37] as
well as in mice [18, 19, 23, 38, 39]. In the present
study, we found a down-regulation of Cldn2 and
Cldn8 in the ileum of A. muciniphila supplemented
mice. However, the intestinal barrier consists of a
complex structure of multiple protein networks [40].
Therefore, it is not possible to draw any solid conclu-
sions on the effects of A. muciniphila supplementation
on intestinal barrier function based on gene expres-
sion data only.
Gut microbiota composition and bacterial diversity in
ileum and colon were not significantly changed after
supplementation with A. muciniphila. This result indi-
cates that bacterial supplementation with A. muciniphila
does not lead to a reshaped gut microbiota composition,
which was also reported before [23]. Gut microbiota
analysis revealed that the relative abundance of A. muci-
niphila was low in ileal and colonic content. It was pre-
viously shown that Akkermansia spp. was more present
in colon than ileum in mono-colonised mice [39], but
Fig. 8 Distribution of inflammatory cell frequencies in spleen after supplementation with Akkermansia muciniphila. a Mean frequencies of total
CD11b+CD68+ monocytes. b Flow cytometric analysis of live single CD11b+ Ly6C/CD68 cells, divided in Ly6Chi, Ly6Cint, Ly6Clo monocytes and
CD68dimLy6Cint/hi neutrophils. c Mean frequencies of Ly6Chimonocytes, (d) Ly6Cint monocytes and (e) neutrophils. (f) Representative pictures of H&E
stained colon and ileum tissue of control and A. muciniphila supplemented mice. Data represent the mean + SEM from five to six mice per
group. *p < 0.05
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the low abundance in colon was remarkable. The dose
of the bacterium, i.e. 2 × 108 CFU for 3 times a week, was
already proven effective in previous mice studies [23]. Pos-
sibly, the relatively long time between the last oral gavage
and sacrifice (about 24 h) could have led to a washout
of A. muciniphila. Though, a recent study showed that
daily supplementation with 11 probiotic strains resulted
in low colonization in mice which was caused by the
A B C
D
G
H I KJ
E F
Fig. 9 Distribution of immune cells in the peritoneum after supplementation with Akkermansia muciniphila. a Absolute number of total peritoneal
exudate cells (PEC), (b) CD3−CD19+ B cells, (c) CD5+CD43+ B1 cells and (d) CD3+ T cells, (e) CD11b+ cells and (f) CD11b+Ly6G+ neutrophils. g
Flow cytometric analysis of CD11b+ cells. h Absolute numbers of CD11b+Ly6G− resident macrophages in peritoneal exudate cell suspension. i
Median Fluorescence Intensity (MFI) of CD115 marker, (j) CD11b marker and (k) SIRPa marker expressed on resident macrophages. Data represent
the mean + SEM from five to six mice per group. *p < 0.05; **p < 0.01
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indigenous microbiome [41]. Possibly, this finding may
also explain the impeded colonization of A. muciniphila
in our study.
Bacterial supplementation with A. muciniphila resulted
in a down-regulation of numerous immune-related genes
and pathways in colon. Notably, these included several B
cell related genes, such as immunoglobulins, Blk and
Pilrb1, amongst others. Moreover, GSEA revealed a
down-regulation of the pathway “Intestinal immune net-
work for IgA production”. These results imply that A.
muciniphila supplementation may have decreased the ne-
cessity for producing IgA, i.e. exerting a mucosal protect-
ive reaction against commensal bacteria [42]. In line with
these results, we found a down-regulation of both Tlr7
and Tlr12 in colon. However, we could not confirm this
hypothesis, since IgA concentrations in colon were not
measured during this study. We did investigate B cell fre-
quencies in several immune tissues. Nevertheless, we
could not find differences in B cell frequencies in MLNs,
whereas B cell frequencies were increased in spleen and
BM. These findings suggest that based on transcriptome
analysis, A. muciniphila decreased B cell frequencies and
CD4+ T cells in colon and caused a potential redistribu-
tion of B and T cells among lymphoid organs. Conversely,
frequencies of total B cell subsets in BM and spleen
were slightly increased after A. muciniphila supplemen-
tation, with no change in B cell precursor frequencies
in BM. These findings may indicate that supplementa-
tion with A. muciniphila inhibited influx of B cells into
the colon, leading to a slightly increased mature B cell
pool in spleen and BM.
Furthermore, we found a decrease in inflammatory
markers in colon after A. muciniphila supplementation.
Several genes encoding for chemokines, complement fac-
tors, as well as the cytokine Il5 were down-regulated after
A. muciniphila supplementation. Besides, IPA identified
numerous pro-inflammatory cytokines as potentially inhib-
ited upstream regulators in colon. The anti-inflammatory
properties of A. muciniphila are already extensively
described [34]. We now add evidence that A. mucini-
phila might protect against the aging-related increase
in inflammation (inflamm-aging) by decreasing the co-
lonic expression of pro-inflammatory genes and path-
ways. Besides, we also identified the anti-inflammatory
cytokine Tgf-beta as inhibited upstream regulator. Al-
though we only found one anti-inflammatory cytokine,
this finding may point toward a general reduction of
immune activation by A. muciniphila. Histological
analysis of the colon did not reveal any clear signs of
immune infiltration in both groups. In a previous
study by Derrien and colleagues, an up-regulation of
immune related genes with no signs of microscopically
visible inflamed tissue was also observed in mice
mono-colonized with A. muciniphila [39]. The authors
suggest that these observations were part of regulatory
processes of immune tolerance toward A. muciniphila.
However, in this study germ-free mice were used, hence
any comparisons between these particular results and our
results should be made with caution.
Interestingly, we found significantly lower frequencies of
activated B cell subtypes and higher frequencies of more
immature B cell subtypes in PP. The increased level of
inactive immature B cells is in accordance with the micro-
array results from ileum tissue, since we also found de-
creased expression of numerous immunoglobulin-related
genes. Besides, Reg3b and Reg3g were both down-regulated
in ileum. We previously showed that A. muciniphila
supplementation also decreased Reg3g expression in
ileum of mice fed a high-fat diet [19]. In a recent
study, an increased expression of antimicrobial genes
was found in the ileum of aged C57BL/6 mice, in-
cluding Reg3b, Reg3g, Defb1 and Retnlb, which was
suggested to be related to an increased state of epi-
thelial distress [43]. Hence, based on our findings we
suggest that supplementation with A. muciniphila
might contribute to prevention of the age-related
state of epithelial distress in ileum.
It is well-known that T cell function declines during
the aging process [44]. Our previous study revealed that
supplementation with L. plantarum WCFS1 and L. casei
BL23 increased regulatory T cell frequencies in MLN of
Ercc1−/Δ7 mice. However, supplementation with A. muci-
niphila did not lead to any changes in T cell distribution
in MLN, spleen and PP, despite a down-regulation of the
Cd4 gene in colon and the predicted inhibition of the
upstream regulator TCR. Possibly, the increased colonic
mucus layer caused by A. muciniphila supplementation
resulted in an increased protective state in the colon,
thereby decreasing the production of a number of T cell
attracting chemokines and subsequently leading to a de-
crease of CD4+ T cell attraction and infiltration.
In the peritoneal cavity, a highly significant increase in
resident macrophages was observed after A. muciniphila
supplementation. Peritoneal macrophages are important
in the modulation of immune responses during infec-
tions and contribute to tissue homeostasis [45]. Further-
more, peritoneal resident macrophages were shown to
defend against microbial invasion [46], which could
explain the high presence of this cell type after supple-
mentation with A. muciniphila. However, this increase
in peritoneal resident macrophages was not coincided
with increased frequencies of neutrophils and T cells,
while these cell types are expected to be highly present
during inflammation. This observation implies that
supplementation with A. muciniphila resulted in an
activated state with regard to peritoneal resident macro-
phages, but resulted in an anti-inflammatory rather than a
pro-inflammatory response.
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Conclusions
The attention for A. muciniphila as a potential microbial
supplement has increased and ample evidence exists
emphasising the beneficial effects of this bacterium on
low-grade inflammation and (cardio)metabolic disorders
[16, 20, 34, 47]. In the present study, we also observed
that several metabolic processes in ileum, as well as im-
munological processes in both ileum and colon were
affected by A. muciniphila, but now in an aging model.
Furthermore, we convincingly showed that A. mucini-
phila has a protective effect against an age-related decline
in mucus thickness, which was even stronger compared to
L. plantarum WCFS1. Aging is often accompanied by
low-grade inflammation and an increased risk on meta-
bolic syndrome [1, 48], contributing to a decreased quality
of life and a considerable rise in healthcare costs [49]. Our
study showed a causal relationship between A. muciniphila
and attenuation of the aging phenotype, in terms of
preventing the age-related decline in thickness of the
colonic mucus layer and improving immune status.
These results therefore support the therapeutic applica-
tion of A. muciniphila in the aging population and pave
the way for further studies investigating A. muciniphila
as therapeutic intervention contributing to healthy aging.
Further research should focus on the practical aspects for
application in humans, such as the dosage, frequency and
way of administration.
Materials and methods
Mice and study design
In this study, accelerated aging Ercc1−/Δ7 mice were used.
Genotyping of this mouse model was extensively de-
scribed previously by others [28–30]. In short, Ercc1−/Δ7
mice have an impaired DNA repair protein ERCC1, result-
ing in accumulation of a broad variety of DNA lesions and
consequently accelerated aging. Mice were individually
housed under SPF conditions, received an ad libitum puri-
fied diet (formula D12450B, Research Diets, Additional
file 5a) and had ad libitum access to water supplied by
water bottles with long nozzles. Mice were supplemented
with Akkermansia muciniphila MucT (ATTC
BAA-835) by oral gavage at a dose of 2 × 108 CFU/200 μL,
three times a week, for a total of 10 weeks. Oral gavages
were given in the morning. The control group simultan-
eously received oral gavages containing the same volume
of PBS. A third Ercc1−/Δ7 mice group was included that re-
ceived the same dose of Lactobacillus plantarum WCFS1.
These mice were only used for histological purposes.
Growing procedures of the bacterial cultures was exten-
sively described previously [29]. A number of 18 mice per
group (both male and female) was included and lifespan
of these mice was assessed. After 10 weeks, when the mice
were 16 weeks old, a number of 5–6 female mice were
sacrificed. Colonic and ileal content, as well as distal
ileum and proximal colon sections, were collected and
snap-frozen in liquid nitrogen. A piece of ileal and co-
lonic tissue was fixed in Carnoy’s solution for histo-
logical purposes. Spleen, mesenteric lymph nodes, Peyer’s
patches, bone marrow and peritoneal exudate cells were
isolated for immunological measurements.
Histology
After paraffin embedding, Carnoy-fixed distal ileum
and proximal colon tissue were sliced in 5 μM sections
on poly-l-lysine coated glass slides (Thermo Scientific,
Germany). Slides were dewaxed, dehydrated and stained
with hematoxylin and eosin (H&E) and PAS/Alcian blue.
The thickness of the colonic mucus layer was measured
using ImageJ software (NIH, MD, USA). For comparison
of the mucus layer thickness, we included an extra mouse
group that received Lactobacillus plantarumWCFS1.
Microbiota composition analysis
DNA was isolated from ileal and colonic content using a
modified repeated bead beating method [50]. Microbiota
composition was assessed using 16S rRNA sequencing on
the MiSeq platform (Illumina, San Diego, CA, USA).
Next, the NG-Tax pipeline was used for barcode-primer
filtering, de-multiplexing, OTU picking and taxonomic
classification [51]. The generated biom-files were used for
summarizing the microbiological data, i.e. alpha-diversity
and beta-diversity, using the R-packages microbiome [52]
and phyloseq [53].
RNA isolation
RNA was isolated from distal ileum and proximal colon
tissue (n = 5–6 mice/group) using TRIzol reagent (Invi-
trogen, Breda, The Netherlands). Purification of the
isolated RNA was performed using the RNeasy Mini kit
(Qiagen, Venlo, The Netherlands). After measurement of
the total RNA yield (Nanodrop, ND-1000, Nanodrop
Products, Maarssen, The Netherlands), RNA integrity
was assessed (Agilent 2100 Bioanalyzer, Agilent
Technologies, Amsterdam, The Netherlands) and
only RNAs were included with a RNA integrity
number (RIN) above 8.0.
Microarray analysis
Microarray analysis was performed as described previ-
ously [54]. Differences in gene expression between the
control and A. muciniphila supplemented mice groups
were assessed using the Intensity Based Moderated T
statistics (IBMT) method, with p-values < 0.05 and fold
changes <− 1.2 or > 1.2. Microarray data has been sub-
mitted to the NCBI Gene Expression Omnibus (GEO)
(GSE126730). Gene Set Enrichment Analysis (GSEA)
was used to identify significantly enriched pathways [55].
Only pathways with a False Discovery Rate (FDR) < 0.2
van der Lugt et al. Immunity & Ageing            (2019) 16:6 Page 14 of 17
were taken into consideration. Ingenuity pathway ana-
lysis (IPA) was used for the identification of upstream
regulators [56].
cDNA synthesis and real-time quantitative PCR
Real-time quantitative PCR (qPCR) was used to validate
the expression profiles of a selection of differentially
expressed genes identified in the microarray analysis.
For both colon and ileum samples, complementary DNA
(cDNA) was synthesized from 1000 ng of total RNA
using the RevertAid First Strand cDNA Synthesis Kit
(Thermo-Fisher Scientific, Landsmeer, The Netherlands)
following the manufacturer’s protocol. The following
thermal cycling conditions were used: 5 min at 25 °C, 60
min at 37 °C and 5min at 70 °C. Primer sequences were
obtained at the online PrimerBank database (Additional
file 5b) [57]. qPCR was performed with a CFX384 thermal
cycler (Bio-Rad Laboratories, Veenendaal, the Netherlands)
using the SensiMix SYBR No-ROX kit (Bioline, Alphen
aan den Rijn, The Netherlands). The housekeeping gene
36B4 was used for normalization.
Fluorescence-activated cell sorting (FACS) analysis
Spleen, mesenteric lymph nodes, Peyer’s patches, bone
marrow and peritoneal exudate cells were all subject to
FACS analysis, similar as previously reported [29]. In brief,
femurs, tibias, ileac crests, forelegs, and sternum were har-
vested and crushed with mortar and pestle. Singe-cell sus-
pensions from each organ were prepared by passing cells
through a 40-μm cell strainer with a syringe. First, cells
were stained for extracellular markers. Fixable live/dead
eFluor506 stain (Ebioscience, San Diego, USA) was used
to exclude dead cells. Cells were fixed and permeabilized
with Fix/Perm buffer (Ebioscience) to stain for intracellu-
lar markers. All antibodies used for flow cytometry are en-
listed in Additional file 5c. A Canto II flow cytometer was
used (BD Biosciences, Erembodegem, Belgium) and data
analysis was performed using FlowJo vX.07 software (Tree
Star Inc., USA).
Statistical analysis
The Kolmogorov-Smirnov test was used to test if data were
normally distributed and appropriate non-parametric statis-
tical tests were used when data were not normally distrib-
uted. With regard to the survival analysis, the log-rank
(Mantel-Cox) test was used. To test differences between
the control and supplemented group, a student t-test or
Mann-Whitney U test was performed. With regard to the
differences in mucus thickness, a Kruskal-Wallis test
with Dunn’s multiple comparisons test was performed,
since three mouse groups were involved. Unless other-
wise stated, p-value levels of p < 0.05 were considered
as statistically significant.
Additional files
Additional file 1: Gene expression profiles (Microarray analysis) of
colon and ileum. Only genes that were statistically significantly different
(p < 0.05) and had a fold change (FC) < − 1.2 or > 1.2 between groups are
included. (XLSX 64 kb)
Additional file 2: Gene set enrichment analysis (GSEA) results of ileum
and colon. Only significantly enriched pathways (FDR < 0.2) are included.
(XLSX 25 kb)
Additional file 3: Relative gene expression of (A) Regenerating
islet-derived 3 beta (Reg3b), (B) Regenerating islet-derived 3 gamma
(Reg3g), (C) Claudin 2 (Cldn2), (D) Claudin 8 (Cldn8), (E) Catenin (cadherin
associated protein), alpha 3 (Ctnna3) and (F) ST6 (alpha-N-acetyl-neuraminyl-
2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
(St6galnac6) in ileum. (G) Relative expression of C-X-C motif chemokine lig-
and 13 (Cxcl13), (H) B lymphoid kinase (Blk), (I) Cluster of differentiation 4
(Cd4), (J) Cluster of differentiation 72 (Cd72), (K) Toll-like receptor 7 (Tlr7), (L)
Toll-like receptor 12 (Tlr12) in colon. (PDF 266 kb)
Additional file 4: Survival rates and body weight of Ercc1−/Δ7 mice. (A)
Percent survival of all mice. These data include 12–13 mice per group
with an additional 5–6 per group censored at 16 weeks. (B) Percentage
survival of only male mice (n = 8–10/group) and (C) female mice
(n = 8–10/group). (D) Body weight in grams measured weekly in all
mice (n = 18 mice per group), (E) male mice (n = 8–10/group) and (F)
female mice (n = 8–10/group). NB: A number of 5–6 female mice was
sacrificed at 16 weeks. (PDF 261 kb)
Additional file 5: (A) Table with diet composition. (B) Table with primer
sequences used for qPCR. (C) Table with a list of antibodies used in flow
cytometry. (DOCX 21 kb)
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